40% of providers plan to keep COVID-19 protocols in place post-pandemic

An overwhelming majority of medical professionals indicated safety standards improved at their organization during COVID-19 and at least 40% of those changes are likely to become permanent, new survey data suggests.

The findings come from Inteleos, a non-profit certification group dedicated to health standards and patient safety. The Rockville, Maryland, organization queried more than 500 healthcare providers for their findings, shared Tuesday.

Overall, 63% indicated that COVID led to new practice efficiencies, including patient pre-registrations and telehealth visits, among other habits.

About 60% actually put those changes into action and 40% plan to keep them in place long after the health crisis is over.

“It has been an incredibly challenging year-and-a-half for everyone in the healthcare profession,” said chair of the Inteleos board Heather Richoux. “We were pleased to see that many medical professionals were able to quickly adopt and adjust to new and existing processes and procedures and will now keep them in place to increase patient safety and efficiency.”

Diving further into the responses, the company found about 71% believe safety standards increased while another 59% said the same for care standards overall.

Healthcare institutions around the world were forced to cancel screening exams and other non-emergent care during the height of COVID-19, with three-quarters of practices surveyed at least 75% back to pre-pandemic levels. But given that 25% continue to struggle, the crisis is not yet over, the researchers noted.

Inteleos boasts a community of more than 158,000 medical pros and governs multiple organizations, including the American Registry for Diagnostic Medical Sonography and the Alliance for Physician Certification & Advancement, among others.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.